thiru's blog

WTO TRIPS Council: Brazil, China, Fiji, India, and South Africa table agenda item on IP and the Public Interest

On 31 May 2017, the delegations of Brazil, China, Fiji, India, and South Africa tabled a paper to the World Trade Organization's (WTO) TRIPS Council entitled "Intellectual Property and the Public Interest." In their communication (IP/C/W/630), the proponents called for a series of discussions at the WTO TRIPS Council on Intellectual Property and the Public Interest. Brazil, China, Fiji, India, and South Africa proposed compulsory licensing as the first theme of IP and the Public Interest discussions at the TRIPS Council meeting in June 2017.

WHO donors in 2016 (US, Gates Foundation, UK, GAVI Alliance, Japan): Setting the agenda for global public health?

In the run up to the 70th World Health Assembly (22 May 2017 - 31 May 2017), the World Health Organization prepared a document (A70/INF./4, 16 May 2017) entitled, Voluntary contributions by fund and by contributor, 2016. Total voluntary contributions to WHO in 2016 amounted to $1,717,219,177 which represented a dip from the 2015 figure of $1,836,970,206.

Here is a non-exhaustive list detailing the sources of voluntary contributions to WHO and the size of their respective contributions in 2016.

WHA70: Statement of India (SEARO) on cancer prevention and control in the context of an integrated approach

On Tuesday, 30 May 2017, India, on behalf of the WHO South-East Asia Region, delivered the following intervention on Cancer prevention and control in the context of an integrated approach.

SEAROcancerstatement.png

WHA70: Statement of Portugal on the Global shortage of, and access to medicines and vaccines

Portugal delivered the following statement at the 70th World Health Assembly on agenda item, 13.3 - Global shortage of, and access to medicines and vaccines.

PortugalWHA70.png

In relation to the Report of the United Nations High-Level Panel on Access to Medicines (UNHLP), the delegation of Portugal quoted the intervention delivered by the Portuguese Minister of Health, Professor Campos Fernandes at the plenary of the 70th World Health Assembly.

WHA70: Statement of Knowledge Ecology International - CEWG follow up

On Friday, 26 May 2017, Knowledge Ecology International delivered the following intervention on the Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. The statement was delivered by Thiru Balasubramaniam.

13.5 Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination

Statement:

In May 2016, the 69th World Health Assembly (WHA) requested (WHA69.23) the Director-General:

WHA70: Statement of Knowledge Ecology International on review of the GSPOA-PHI

On Friday, 26 May 2017, Knowledge Ecology International delivered the following intervention on the Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property. This statement was read by Manon Ress.

13.4 Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property

The GSPOA evaluation conducted by Capra International was disappointing, raising questions about the terms of reference, and low ambition.

WHA70: Statement of Knowledge Ecology International: Review of the Pandemic Influenza Preparedness Framework

On Thursday, 25 May 2017, Knowledge Ecology International (KEI) delivered the following intervention on the Review of the Pandemic Influenza Preparedness Framework (PIP) at the 70th session of the World Health Assembly (WHA).

WHA70: Statement of Knowledge Ecology International on Research and development for potentially epidemic diseases

On Wednesday, 24 May 2017, Knowledge Ecology International delivered its maiden statement to the World Health Assembly on the topic of research and development for potentially epidemic diseases. The intervention was read by Diane Singhroy, PhD.

Seventieth World Health Assembly (A70/1)
Agenda Item: 12.1.3 Research and development for potentially epidemic diseases

WHA70 - Side Event on Addressing Access Barriers and Affordability Challenges for Cancer Drugs - 24 May 2017

On Wednesday, 24 May 2017, Knowledge Ecology International (KEI), Oxfam and Stichting Health Action International (HAI) are convening a side event on addressing access barriers and affordability challenges for cancer medicines. This panel will take place in Salle IX of the United Nations Palais des Nations from 18:00 to 19:30.

Date: Wednesday, 24 May 2017
Time: 18:00 to 19:30
Location: Salle IX, United Nations Palais des Nations

Panelists:

Berlin Declaration of the G20 Health Ministers

After at least eight rounds of negotiation, including two Geneva-based negotiations held on 12 May 2017 and 17 May 2017, the G20 Health Ministers meeting, convened in Berlin from 19-20 May 2017 issued the following declaration.

In relation to the R&D pipeline for developing new antimicrobial therapies, the G20 recognized "the importance of fostering R&D for new antimicrobials, alternative therapies, vaccines and rapid-point-of care diagnostics, in particular for priority pathogens as identified by WHO and for tuberculosis."

SCCR34: Atmospherics of WIPO negotiations on a broadcasting treaty

Currently, the WIPO Standing Committee on Copyright and Related Rights (SCCR) is engaged in negotiations on a Treaty for the Protection of Broadcasting Organizations, an exercise dating back to 1998. (Source: Timeline of WIPO negotiations on a Treaty for the Protection of Broadcasting Organizations).

KEI statement: 21st meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines

On Monday, 27 March 2017, Knowledge Ecology International (KEI) delivered the following oral statement to the Open Session of the 21st Meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines. The program for the open session can be found here.

14 March 2017 - Senate Finance Committee grills Robert Lighthizer (USTR nominee) on trade and IPR policies

On 14 March 2017, the U.S. Senate Finance Committee held confirmation hearings for Robert Lighthizer, President Donald Trump's appointee for United States Trade Representative. During the Reagan administration, Lighthizer served as Deputy US Trade Representative with the rank of Ambassador (Source: http://www.presidency.ucsb.edu/ws/?pid=41174). Prior to his tenure as Deputy USTR, from 1981 to 1983, Lighthizer served as Chief Counsel for the U.S. Senate Finance Committee. Currently, he is a partner at Skadden Arps.

8 March 2017 - Statement of Portugal - HRC 34 - Panel on Access to Medicines

On 8 March 2017, the Permanent Representative of Portugal, Ambassador Pedro Nuno Bártolo, made a powerful intervention at the Human Rights Council's panel discussion on access to medicines. Portugal stressed that access to medicines is a fundamental element of the right to health and highlighted how the high prices of hepatitis C and cancer medicines made them unaffordable to large segments of the population in industrialized countries.

8 March 2017 - Statement of the European Union - HRC 34 - Panel on Access to Medicines

On 8 March 2017, the European Union (EU) delivered the following statement to the Human Rights Council's panel discussion on Access to Medicines. As the Human Right Council imposed a strict two minute limit on interventions, the EU was not able to raise the following two questions contained at the end of its intervention.

I have two questions for the Panel.

Could the panellists suggest further measures to promote a holistic approach to access to medicines?

Syndicate content